- - -
 
Ceo Roundtable   Come visit the Roundtable
 
 
Home Ceo Groups Seminars & Retreats Member Directory Newsletter News Contact Us
 
   
 
Links
-
     
  -
-
  -
-
  -
-
  -
-
  -
     
Testimonials
"I trust recommendations from my peer group for good resources that will be right ...
Kees Been
CEO, EnVivo Pharmaceuticals
It is my pleasure to tell about the benefits of the CEO Roundtable. Although I have only been a member ...
Janet Wolfe
CEO, Wolfe Laboratories
Read More...     
 
Newsletter Sign Up
 
Sign up to receive CEO Roundtable
News
Read Recent Issue Sign Up
 
-
Members in the News
-
-
 
August 2010 July 2010 June 2010 May 2010
April 2010 March 2010 February 2010 January 2010
December 2009 November 2009 October 2009 September 2009
August 2009 July 2009 June 2009 May 2009
April 2009 March 2009 February 2009 January 2009
December 2008 November 2008 October 2008 September 2008
August 2008 July 2008 June 2008 April 2008
March 2008 February 2008 2008 2007
2007a 2006 2005 2004
 
Members in the News - January 2010
 
-
 
Date: January 12, 2010
Subject:
Member in the News: Satish Tadikonda, Virtify, raise $15M round A
 
Satish Tadikonda, CEO and founder of Virtify, announced the closing on series A of $15m, according to Mass High Tech.
 
Read More
 
-
 
Date: January 20, 2010
Subject:
Member in the News: Dan Leary, Nexamp get $6.5 million in Series A financing
 
Dan Leary, the founder and president of Nexamp, an alternative energy company, raised $6.5 million in a Series A financing led by RCG Ventures and Point Judith Capital.
 
Read More
 
-
 
Date: January 27, 2010
Subject:
Member in the News: Walter Ogier, Acetylon, adds $2m to round A
 
Walter Ogier, CEO of Acetylon Pharmaceuticals, announced that the company raised an additional $2m from a private investor, bringing the total raised to $9.25m.
 
Read More
 
-
 
Date: January 28, 2010
Subject:
Member in the News: Kees Been, EnVivo Pharmaceuticals, selected for $611,000 grant from Michael J. Fox Foundation
 
Kees Been, CEO of EnVivo Pharmaceuticals, announced that the company has been selected by the Michael J. Fox Foundation for Parkinson's Research to receive a $611,000 grant toward preclinical studies of EnVivo's drug target designed to slow the progression of Parkinson's disease.
 
Read More
 
-
 
 
 
 
 
- - -
  Website Designed and Developed By ListEngage, Inc